Brief: Tot Biopharm International Records HY Revenue Rmb182.0 Mln
12/08/2022 16:07
Aug 12 (Reuters) - TOT BIOPHARM International Co Ltd
1875.HK :
* HY REVENUE RMB182.0 MILLION VERSUS RMB23.1 MILLION
* HY LOSS ATTRIBUTABLE RMB15.7 MILLION VERSUS RMB115.0
MILLION
Further company coverage: 1875.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioDlink International
See all newsCorrected: China's BioDlink International HY revenue falls (September 29)
Brief: Biodlink International To Deliver Ten Batches Of Monoclonal Antibody Intermediates To Wuxi Biologics
Brief: Biodlink International Says Shan Fu Resigns As Executive Director And Chairperson
Brief: BioDlink International Says WuXi XDC Cayman To Make Conditional Cash Offer For All Co Shares
Brief: HKEX Says Trading In Shares Of Biodlink International Will Be Halted At Dec 29